Device Trial Radar · NCT07590518
VR Therapies for IBD
Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Enrolling by invitation
Enrollment
76
Planned (sponsor's estimate)
Start
Sep 29, 2026
Primary completion
Jun 2027
Study completion Jul 2027
Sponsor
- Lead sponsor
- Brennan SpiegelAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Chicago
- First posted
- May 15, 2026
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Through a pilot randomized controlled trial (RCT), the aim is to test the clinical impact and feasibility of a AI-enhanced Virtual Reality (VR) Cognitive Behavioral therapy (CBT) program versus distraction VR among patients with inflammatory bowel disease (IBD) and anxiety. It is hypothesized that using VR/AI CBT may reduce anxiety and IBD symptoms, leading to improved overall physical, psychological, and social functioning when compared to distraction VR.
Conditions
- Inflammatory Bowel Disease (IBD)
- Ulcerative Colitis (UC)
- Crohn Disease (CD)
- Anxiety
Interventions
Distraction VRDevice
Distraction-based VR program with 2D nature videos to be used for 8-weeks for 10-20 minutes per week.
VR/AI CBTDevice
8-week protocolized VR/AI CBT program
Primary outcomes
What the sponsor says the trial is designed to measure.
- Generalized Anxiety Disorder-7 (GAD-7)Time frame: Bi-weekly; Baseline through Week 8
- System Usability Scale (SUS)Time frame: Week 8
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Cedars-Sinai Medical Center
Los Angeles, California
University of Chicago
Chicago, Illinois
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.